Pharmaceutical Legislation Course

Lesson 1 • Objectives of Pharmaceutical Law

Examines the three pillars: safety, efficacy, and quality. Connects legislative intent to practical regulatory requirements.

Lesson 2 • History of Drug Regulation

Traces key events that prompted formal pharmaceutical oversight. Provides context for understanding why current regulatory frameworks exist.

Lesson 3 • Structure of Regulatory Authorities

Maps the organisational design of drug agencies at national and supranational levels. Shows how authority is delegated and exercised.

Lesson 4 • Sources of Pharmaceutical Law

Identifies primary, secondary, and soft-law instruments governing pharmaceuticals. Explains how guidelines, directives, and regulations interact.

Lesson 1 • Special Categories of Medicines

Covers biologics, advanced therapy products, orphan drugs, and biosimilars as distinct regulatory classes. Highlights unique approval pathways for each.

Lesson 2 • Controlled Substance Scheduling

Details the scheduling of substances with abuse potential under international and national frameworks. Addresses storage, record-keeping, and supply chain controls.

Lesson 3 • Classification of Combination Products

Addresses products combining drug, device, or biologic components. Explains how primary mode of action determines the lead regulatory pathway.

Lesson 4 • Principles of Drug Classification

Explains the criteria regulators use to assign medicines to categories. Links classification outcomes to access, labeling, and distribution rules.

Lesson 1 • Investigational Medicinal Product Rules

Addresses manufacturing, labeling, and supply chain requirements for investigational products. Covers import and export controls for trial materials.

Lesson 2 • Trial Registration and Results Disclosure

Covers mandatory trial registration and public disclosure of results. Addresses legal consequences of non-disclosure and data transparency obligations.

Lesson 3 • Clinical Trial Authorisation Requirements

Covers the submission, review, and approval process for clinical trial applications. Explains the roles of regulatory authorities and ethics committees.

Lesson 4 • Safety Reporting in Clinical Trials

Explains expedited and periodic safety reporting obligations during trials. Covers SUSAR reporting timelines and development safety update reports.

Lesson 1 • Common Technical Document Structure

Explains the internationally harmonised dossier format used for drug applications. Students learn to organise quality, safety, and efficacy data correctly.

Lesson 2 • Approval Pathways and Procedures

Compares standard, accelerated, conditional, and exceptional-circumstances pathways. Identifies eligibility criteria and procedural timelines for each.

Lesson 3 • Pre-Submission Planning

Covers scientific advice, pre-submission meetings, and dossier strategy. Establishes how early regulatory engagement reduces approval risk.

Lesson 4 • Variations and Post-Approval Changes

Distinguishes minor, major, and type-II variations to an approved authorisation. Explains notification, approval, and implementation obligations.

Lesson 1 • Qualified Person Responsibilities

Defines the legal role and personal liability of the Qualified Person in batch certification. Explains how this role interfaces with regulatory authorities.

Lesson 2 • GMP Inspections and Enforcement

Describes inspection types, frequency, and outcomes under GMP law. Covers responses to deficiencies, warning letters, and manufacturing suspensions.

Lesson 3 • GMP Principles and Quality Systems

Covers the core GMP principles: personnel, premises, equipment, documentation, and process validation. Builds understanding of a compliant quality management system.

Lesson 4 • GMP for Active Substance Manufacturers

Extends GMP obligations to active pharmaceutical ingredient producers. Addresses audit rights, supply chain verification, and written confirmation requirements.

Lesson 1 • Adverse Drug Reaction Reporting

Covers spontaneous reporting obligations for healthcare professionals and marketing authorisation holders. Explains expedited and periodic reporting timelines.

Lesson 2 • Legal Framework for Pharmacovigilance

Identifies the legislative basis for post-authorisation safety monitoring. Explains how pharmacovigilance law integrates with marketing authorisation conditions.

Lesson 3 • Pharmacovigilance System Master File

Defines the content and maintenance requirements of the PSMF. Links PSMF compliance to inspection readiness and authorisation validity.

Lesson 4 • Risk Management and Minimisation

Explains risk management plan requirements and additional risk minimisation measures. Covers regulatory review of risk management effectiveness.

Lesson 1 • Falsified Medicines Legislation

Explains the legal definition of falsified medicines and the obligations it creates. Covers safety features, verification systems, and reporting duties.

Lesson 2 • Parallel Trade and Importation Rules

Covers the regulatory conditions under which parallel-imported medicines may be sold. Addresses relabeling, repackaging, and notification requirements.

Lesson 3 • Online Pharmacy and Distance Selling

Explains the legal framework for internet sale of medicines. Covers registration, common logo requirements, and prohibited online sales categories.

Lesson 4 • Supply Chain Integrity Requirements

Addresses verification, traceability, and documentation obligations across the supply chain. Links integrity failures to legal liability.

Lesson 1 • Mandatory Labeling Requirements

Identifies the legally required elements on outer packaging, immediate packaging, and package leaflets. Covers readability and language obligations.

Lesson 2 • Braille and Accessibility Requirements

Covers legal obligations to include Braille on packaging and ensure patient accessibility. Links accessibility requirements to labeling approval.

Lesson 3 • Enforcement of Advertising Standards

Covers the mechanisms for monitoring, challenging, and sanctioning non-compliant promotion. Addresses self-regulatory and statutory enforcement bodies.

Lesson 4 • Advertising to Healthcare Professionals

Defines permissible promotional content and the prohibition on misleading claims. Covers hospitality, samples, and inducement restrictions.